News Detail
Ahmedabad & Hyderabad, 30 June 2024: Zydus Lifesciences Limited (including its subsidiaries/affiliates hereafter referred to as “Zydus”) a discovery-driven global life sciences company and Dr. Reddy’s Laboratories Ltd., along with its subsidiaries hereafter ......
View Details
Source : Dr Reddy's
Zydus Lifesciences
Dr. Reddy’s Laboratories
licensing agreement
Pertuzumab biosimilar
Sigrima™
Womab®
Related News
- Govt launches portal to tackle drug abuse in children (02-07-2024)
- Drugmakers' appeal to end Zantac cancer lawsuits rebuffed by judge (02-07-2024)
- Man who illegally imported unlicensed medicines from India, sentenced at Southwark Crown Court (02-07-2024)
- Punjab HM bats for bringing parity in prices of same salt medicines (02-07-2024)
- After Gilead and J&J lawsuits, Safe Chain owners charged with wire fraud, conspiracy (02-07-2024)
- Indian national charged with selling counterfeit drugs (02-07-2024)
- Punjab police bust illegal pharma drug Unit, 4 arrested (02-07-2024)
- Pharma sector sees Rs. 29,268 crore increase under PLI scheme by May 2024 (01-07-2024)
- Mumbai: Drug lord reveals a web of ops (01-07-2024)
- UP Man Arrested in Major Fake Medicine Racket (01-07-2024)